Navigation Links
DOV Pharmaceutical, Inc. Begins Trading on OTC Bulletin Board
Date:8/28/2007

SOMERSET, N.J., Aug. 28 /PRNewswire-FirstCall/ -- DOV Pharmaceutical, Inc. ("DOV" or the "Company") (OTC Bulletin Board and Pink Sheets: DOVP) announced today that its common stock is now being quoted on the OTC Bulletin Board. The Company understands that its common stock is also still being quoted on the Pink Sheets.

"We are pleased that shares of our common stock are now being quoted both on the OTC Bulletin Board and the Pink Sheets," said Barbara Duncan, Chief Executive Officer of DOV. "We believe this dual quotation on the OTC Bulletin Board and the Pink Sheets provides the Company with greater visibility in the investment community and offers our shareholders, both current and future, greater liquidity."

About DOV

DOV is a biopharmaceutical company focused on the discovery, acquisition and development of novel drug candidates for central nervous system disorders. The Company's product candidates address some of the largest pharmaceutical markets in the world including depression, pain and insomnia.

Cautionary Note

Statements in this press release that are not historical facts constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. You can also identify forward-looking statements by the following words: may, will, should, expect, intend, plan, anticipate, believe, estimate, predict, potential, continue or the negative of these terms or other comparable terminology. We caution you that forward-looking statements are inherently uncertain and are simply point-in-time estimates based on a combination of facts and factors currently known by us about which we cannot be certain or even relatively confident. Actual results or events will surely differ and may differ materially from our forward-looking statements as a result of many factors, some of which we may not be able to predict or may not be within our contro
'/>"/>

SOURCE DOV Pharmaceutical, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. DeForest biodiesel plant begins production
2. Deltanoid Pharmaceuticals begins phase II osteoporosis study
3. Prodesse begins clinical trials for flu virus detection
4. Closing the income gap begins with education
5. Corporate control begins with a strong board
6. Emerging game developer begins work on prototypes
7. GE begins human trials for cancer detection agent
8. Now the real work begins
9. Esker begins automated faxing and mailing service
10. Its not exactly OPEC, but Midwest states are trading ideas on biofuels
11. Avoid Trading Tech Relationships Like Pokmon Cards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 2014 WriteResult, LLC – a ... been working with a team of researchers from Yale ... Community Farming Collaborative to provide electronic questionnaire data collection ... study, which started in May, aims to evaluate the ... weekly exposure to and participation in urban agriculture to ...
(Date:10/22/2014)... , Oct. 22, 2014   Synthetic Biologics, ... novel pathogen-specific therapies for serious infections and diseases, announced ... issued a Notice of Allowance for a composition of ... C. difficile program, SYN-004. This is Synthetic ... in the U.S. and adds to the Company,s extensive ...
(Date:10/20/2014)... 2014 The report “Pharmacy Automation ... Packaging and Labeling Systems, Table-top Counters) by End-user ... Forecasts & Trends to 2019” analyzes and studies ... North America, Europe, Asia-Pacific, and the Rest of ... and 30 figures spread through 300 pages and ...
(Date:10/20/2014)... , October 20, 2014 ... gastrointestinal (GI) disorders and the delivery of care has ... diseases and worrying inequalities in the provision of healthcare ... which was commissioned by United European Gastroenterology (UEG), have ... political and public awareness of the burden of GI ...
Breaking Biology Technology:myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 2myPROpad™ Topic of Panel Discussion at the Yale Food Systems Symposium 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 2Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 3Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 4Major Survey Reveals Changing Trends and Inequalities in Healthcare Provision for Gastrointestinal Disorders Across Europe 5
... Technology to Optimize Efficiency and ... Safety and Reduce Cost of Ownership, ST. ... a member of the Sigma-Aldrich Group (Nasdaq: SIAL ),today ... for compound semiconductor manufacturing.,EpiVapor eliminates the need for localized tool ...
... /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:,ONC, NASDAQ: ONCY) ... study of,intravenous REOLYSIN(R) in patients with sarcomas metastatic ... Society of Clinical Oncology,(ASCO) annual meeting. The presentation, ... Reovirus) in the Treatment of Patients with,Bone and ...
... transaction expertise, SAN DIEGO, June 2 ... Truex to its Board of Directors. Truex is,the ... he,served as President and CEO of Peninsula Pharmaceuticals ... (including $21000000 from a key,strategic partner) and negotiated ...
Cached Biology Technology:SAFC Hitech Launches Metalorganic Bulk Vapor Distribution System for Compound Semiconductor Manufacturing 2SAFC Hitech Launches Metalorganic Bulk Vapor Distribution System for Compound Semiconductor Manufacturing 3SAFC Hitech Launches Metalorganic Bulk Vapor Distribution System for Compound Semiconductor Manufacturing 4Oncolytics Biotech Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at ASCO Annual Meeting 2Trius Appoints Paul Truex to Board of Directors 2
(Date:10/16/2014)... how the bowel lining develops and, in the process, ... , The researchers produced evidence that stem cells are ... a feature of the bowel lining, and believe these ... controversial finding as scientists are still divided on the ... Chin Wee Tan and Professor Tony Burgess from the ...
(Date:10/16/2014)... 2014) – Post-menopausal women experienced improvements in vaginal ... or genital bleeding, after 12 weeks of daily ... soy germ-based nutritional supplement previously shown to help ... peer-reviewed pilot study reported in a poster at ... meeting. , "These data documented improved vaginal ...
(Date:10/15/2014)... assess the pandemic risk from strains of influenza virus ... allow ourselves to become complacent that the most substantial ... scientists. , Influenza pandemics arise when a new virus ... widespread immunity – spreads in the human population. There ... years, the worst of which – the 1918 Spanish ...
Breaking Biology News(10 mins):Cryptic clues drive new theory of bowel cancer development 2S-equol supplements associated with improved measures of reproductive health in postmenopausal women 2Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2
... have developed a breed of American chestnut that is resistant ... early 1900s. But the return of this "king of ... more than 100 feet, remains hampered by a slew of ... the verge of overcoming chestnut blight, but there is a ...
... susceptible to air pollution (which can lead to increased ... locations in their everyday lives that contain high levels ... team led by the University of Cincinnati and funded ... Sang Young Son, assistant professor in the University of ...
... MA (09/05/07)--It is well established that a child,s brain ... about the extent to which such plasticity exists in ... MIT and Johns Hopkins University have used converging evidence ... the adult visual cortex does indeed reorganize-and that the ...
Cached Biology News:Challenges remain in reintroducing American chestnut 2Challenges remain in reintroducing American chestnut 3UC's NIH grant brings technology from outer space to playgrounds 2UC's NIH grant brings technology from outer space to playgrounds 3Adult brain can change, study confirms 2